MARKET

PHAR

PHAR

Pharming Group N.V.
NASDAQ
17.67
+0.86
+5.12%
After Hours: 17.67 0 0.00% 16:10 12/31 EST
OPEN
16.77
PREV CLOSE
16.81
HIGH
17.69
LOW
16.61
VOLUME
26.73K
TURNOVER
--
52 WEEK HIGH
18.30
52 WEEK LOW
7.50
MARKET CAP
1.21B
P/E (TTM)
434.15
1D
5D
1M
3M
1Y
5Y
1D
Biotech Stocks Facing FDA Decision In January 2026
NASDAQ · 12/30/2025 08:21
Weekly Report: what happened at PHAR last week (1222-1226)?
Weekly Report · 12/29/2025 10:25
Best Momentum Stocks to Buy for Dec. 22
NASDAQ · 12/22/2025 15:15
Weekly Report: what happened at PHAR last week (1215-1219)?
Weekly Report · 12/22/2025 10:25
Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga · 12/15/2025 13:06
Weekly Report: what happened at PHAR last week (1208-1212)?
Weekly Report · 12/15/2025 10:33
Weekly Report: what happened at PHAR last week (1201-1205)?
Weekly Report · 12/08/2025 10:32
Pharming Group to Join Oppenheimer Movers in Rare Disease Summit
Reuters · 12/08/2025 07:00
More
About PHAR
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Webull offers Pharming Group NV stock information, including NASDAQ: PHAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAR stock methods without spending real money on the virtual paper trading platform.